UPDATED Mar 26, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
FPH | NZ$26.42 | 10.3% | 1.8% | NZ$15.4b | NZ$23.63 | PE59x | E17.3% | 1.5% | Healthcare | ||
EBO | NZ$33.85 | -5.4% | -24.8% | NZ$6.5b | NZ$37.57 | PE23.4x | E6.2% | 3.4% | Healthcare | ||
RYM | NZ$4.42 | -3.1% | -15.2% | NZ$3.0b | NZ$7.51 | PE12.1x | E14.2% | 0% | Healthcare | ||
SUM | NZ$11.30 | 1.8% | 28.7% | NZ$2.7b | NZ$13.13 | PE6.1x | E-7.8% | 2.2% | Healthcare | ||
ARV | NZ$1.07 | 2.9% | 15.1% | NZ$782.2m | NZ$1.45 | PE9.4x | E2.5% | 2.2% | Healthcare | ||
OCA | NZ$0.61 | -1.6% | -18.7% | NZ$441.7m | n/a | PE11.2x | E22.0% | 0% | Healthcare | ||
AFT | NZ$3.05 | 2.7% | -7.6% | NZ$319.8m | NZ$4.51 | PE29.3x | E19.3% | 0.4% | Pharmaceuticals & Biotech | ||
PEB | NZ$0.086 | 0% | -79.0% | NZ$69.8m | n/a | PS2.7x | E40.3% | n/a | Pharmaceuticals & Biotech | ||
RAD | NZ$0.13 | -3.0% | -46.3% | NZ$36.7m | n/a | PB0.5x | n/a | 0% | Healthcare | ||
CBD | NZ$0.098 | -1.0% | n/a | NZ$32.4m | n/a | PS33.9x | n/a | n/a | Pharmaceuticals & Biotech | ||
BLT | NZ$0.017 | 13.3% | -34.6% | NZ$21.7m | n/a | PS2x | n/a | n/a | Pharmaceuticals & Biotech | ||
PHL | NZ$0.001 | 0% | 0% | NZ$21.6m | n/a | PE136.9x | n/a | n/a | Healthcare | ||
TAH | NZ$1.67 | 0.6% | 6.4% | NZ$16.7m | n/a | PE25.4x | n/a | 5.6% | Healthcare | ||
RUA | NZ$0.079 | 1.3% | -60.5% | NZ$12.5m | n/a | PS22x | n/a | n/a | Pharmaceuticals & Biotech | ||
TRU | NZ$0.022 | 10.0% | -21.4% | NZ$12.2m | n/a | PS5.5x | n/a | n/a | Healthcare | ||
GFI | NZ$0.041 | 17.1% | -49.4% | NZ$4.7m | n/a | n/a | n/a | n/a | Pharmaceuticals & Biotech | ||
MEE | NZ$0.079 | -9.2% | -91.2% | NZ$1.2m | n/a | PB0.3x | n/a | n/a | Healthcare |